Holger LauxFellow at Novartis Cell Line Develeopment
Dr. Laux is leading the cell line development network of "Biologics Technical Development & Manufacturing" within Novartis. Throughout his career he focused his work on functional genomics approaches as transcriptomics screens and subsequently cell line engineering editing. These efforts resulted in generation of several improved CHO production cell lines. He was also supporting the sequencing of Chinese hamster resulting in a public available Chinese hamster genome. He is additionally involved in enabling and improving the production of difficult to express therapeutic recombinant proteins.